RTW Investments’s Milestone Pharmaceuticals MIST Stock Holding History

RTW Investments’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.5M	Buy	7,833,336 +1,502,335	+24%	+$2.4M	0.09%	64
2026 Q1	$7.53M	Buy	6,331,001 +3,824,899	+153%	+$6.7M	0.08%	73
2025 Q4	$5.06M	Hold	2,506,102	–	–	0.05%	79
2025 Q3	$5.01M	Hold	2,506,102	–	–	0.06%	69
2025 Q2	$4.86M	Hold	2,506,102	–	–	0.07%	66
2025 Q1	$2.01M	Hold	2,506,102	–	–	0.03%	65
2024 Q4	$5.91M	Sell	2,506,102 -750,000	-23%	-$1.29M	0.09%	59
2024 Q3	$4.95M	Hold	3,256,102	–	–	0.07%	58
2024 Q2	$4.3M	Hold	3,256,102	–	–	0.07%	58
2024 Q1	$5.83M	Hold	3,256,102	–	–	0.09%	60
2023 Q4	$5.44M	Hold	3,256,102	–	–	0.08%	58
2023 Q3	$10.1M	Hold	3,256,102	–	–	0.21%	46
2023 Q2	$9.28M	Hold	3,256,102	–	–	0.18%	51
2023 Q1	$12.8M	Sell	3,256,102 -1,059,000	-25%	-$3.87M	0.27%	40
2022 Q4	$17.1M	Hold	4,315,102	–	–	0.35%	40
2022 Q3	$39.7M	Hold	4,315,102	–	–	0.91%	32
2022 Q2	$26.5M	Hold	4,315,102	–	–	0.69%	35
2022 Q1	$27.7M	Hold	4,315,102	–	–	0.57%	45
2021 Q4	$28.3M	Hold	4,315,102	–	–	0.41%	57
2021 Q3	$24.6M	Hold	4,315,102	–	–	0.37%	56
2021 Q2	$23.7M	Hold	4,315,102	–	–	0.36%	55
2021 Q1	$25M	Hold	4,315,102	–	–	0.39%	57
2020 Q4	$28.9M	Hold	4,315,102	–	–	0.49%	48
2020 Q3	$31.6M	Hold	4,315,102	–	–	0.76%	37
2020 Q2	$16.3M	Hold	4,315,102	–	–	0.46%	45
2020 Q1	$7.94M	Buy	4,315,102 +356,838	+9%	+$6.18M	0.34%	48
2019 Q4	$63.4M	Buy	3,958,264 +436,408	+12%	+$7.72M	2.39%	14
2019 Q3	$63.8M	Hold	3,521,856	–	–	3.8%	7
2019 Q2	$91M	Buy	+3,521,856	New	+$72.6M	4.86%	7

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

RTW Investments's MIST Position: Q2 2026 in Review

RTW Investments increased its Milestone Pharmaceuticals (MIST) stake by 24% in Q2 2026, buying an estimated $2.4M and bringing the position to 7,833,336 shares worth $10.5M. The position accounts for 0.09% of the portfolio, ranked #64.

RTW Investments first reported a position in MIST in Q2 2019 and has held it in 29 quarters since. The position peaked at $91M in Q2 2019. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

RTW Investments held 7,833,336 shares of Milestone Pharmaceuticals worth $10.5M as of Q2 2026.
RTW Investments bought 1,502,335 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.4M.
Milestone Pharmaceuticals made up 0.09% of RTW Investments's portfolio in Q2 2026, its #64 holding.
RTW Investments first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 29 quarters since.
RTW Investments's Milestone Pharmaceuticals position peaked at $91M in Q2 2019.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.